Application Sponsors
Marketing Status
Application Products
001 | TABLET;ORAL | 50MG | 0 | DISIPAL | ORPHENADRINE HYDROCHLORIDE |
FDA Submissions
TYPE 1; Type 1 - New Molecular Entity | ORIG | 1 | AP | 1957-05-10 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 9 | AP | 1975-08-22 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 10 | AP | 1977-04-29 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 11 | AP | 1980-04-28 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 0 |
SUPPL | 9 | Null | 0 |
SUPPL | 10 | Null | 0 |
SUPPL | 11 | Null | 0 |
CDER Filings
3M
cder:Array
(
[0] => Array
(
[ApplNo] => 10653
[companyName] => 3M
[docInserts] => ["",""]
[products] => [{"drugName":"DISIPAL","activeIngredients":"ORPHENADRINE HYDROCHLORIDE","strength":"50MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"DISIPAL","submission":"ORPHENADRINE HYDROCHLORIDE","actionType":"50MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)